R&D Archives | Be Korea-savvy
Gov’t to Nurture Manpower in Bio Industry

Gov’t to Nurture Manpower in Bio Industry

SEOUL, Apr. 12 (Korea Bizwire) — South Korea is set to release a set of support measures, including nurturing talented manpower, to help local pharmaceutical companies make further inroads into the global market, the country’s health minister said Tuesday. The remarks were made during a meeting attended by Health Minister Chung Chin-yeob, and executives of [...]

Samsung Curtails R&D Spending in 2016: Data

Samsung Curtails R&D Spending in 2016: Data

SEOUL, April 2 (Korea Bizwire) – Samsung Electronics Co., the world’s largest manufacturer of smartphones, slightly reduced its expenditures on research and development (R&D) projects last year, data showed Wednesday, as it sought to acquire key technologies through mergers and acquisitions, data showed Sunday.  Samsung Electronics Co. spent 14.79 trillion won (US$13.2 billion) on R&D [...]

S. Korea to Set up 113.5 Bln-Won Fund to Help Bio Startups

S. Korea to Set up 113.5 Bln-Won Fund to Help Bio Startups

SEOUL, March 27 (Korea Bizwire) – South Korea will establish a 113.5 billion-won (US$101.8 million) fund to nurture startups and venture firms in the bio sector to secure new growth engines, the science ministry said Monday. Under the comprehensive plan finalized during a government meeting presided over by Acting President and Prime Minister Hwang Kyo-ahn, [...]

Major Pharmaceuticals to Expand R&D Spending in 2017

Major Pharmaceuticals to Expand R&D Spending in 2017

SEOUL, March 21 (Korea Bizwire) – Major South Korean pharmaceutical companies are poised to expand their spending on research and development (R&D) this year despite weak earnings, industry sources said Tuesday.  The four drug companies — Hanmi Pharmaceutical Co., Green Cross Corp., Daewoong Pharma and Chong Kun Dang Pharmaceutical Corp. — whose annual R&D spending [...]

Less Than 1 in 5 Medical Device Companies to Increase R&D Positions: Survey

Less Than 1 in 5 Medical Device Companies to Increase R&D Positions: Survey

SEOUL, Feb. 20 (Korea Bizwire) – Less than one in five South Korean manufacturers of medical supplies and equipment said they plan to increase new research and development (R&D) jobs, a survey showed Monday, despite the government’s push to become a global biotech and medical industry hub.  According to the survey by the Korea Medical [...]

Annual R&D Spending Tops 100 Bln Won at 4 Korean Drug Firms

Annual R&D Spending Tops 100 Bln Won at 4 Korean Drug Firms

SEOUL, Feb. 14 (Korea Bizwire) – Four major South Korean pharmaceutical companies spent more than 100 billion won (US$86.9 million) each on research and development (R&D) in 2016, industry officials said Tuesday.  The four drug companies — Hanmi Pharmaceutical Co., Green Cross Corp., Daewoong Pharma and Chong Kun Dang Pharmaceutical Corp. — sharply expanded their [...]

Local Pharmaceutical Companies Fall Behind Foreign Rivals

Local Pharmaceutical Companies Fall Behind Foreign Rivals

SEOUL, Jan. 9 (Korea Bizwire) – Only one South Korean pharmaceutical company had a new drug approved in 2016, compared to 11 drugs introduced by overseas companies including Novartis, Gilead Sciences, and Pfizer. Olita Tablet, a lung cancer drug from Hanmi Pharmaceutical, was the only new drug introduced last year by a local company, and [...]